KRYS
Price
$137.06
Change
-$3.27 (-2.33%)
Updated
Jun 13, 04:59 PM (EDT)
Capitalization
3.96B
59 days until earnings call
ROIV
Price
$11.33
Change
-$0.14 (-1.22%)
Updated
Jun 13, 04:59 PM (EDT)
Capitalization
7.67B
66 days until earnings call
Interact to see
Advertisement

KRYS vs ROIV

Header iconKRYS vs ROIV Comparison
Open Charts KRYS vs ROIVBanner chart's image
Krystal Biotech
Price$137.06
Change-$3.27 (-2.33%)
Volume$6.11K
Capitalization3.96B
Roivant Sciences
Price$11.33
Change-$0.14 (-1.22%)
Volume$98.61K
Capitalization7.67B
KRYS vs ROIV Comparison Chart
Loading...
KRYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KRYS vs. ROIV commentary
Jun 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KRYS is a Hold and ROIV is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 14, 2025
Stock price -- (KRYS: $140.33 vs. ROIV: $11.47)
Brand notoriety: KRYS and ROIV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KRYS: 122% vs. ROIV: 70%
Market capitalization -- KRYS: $3.96B vs. ROIV: $7.67B
KRYS [@Biotechnology] is valued at $3.96B. ROIV’s [@Biotechnology] market capitalization is $7.67B. The market cap for tickers in the [@Biotechnology] industry ranges from $355.9B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KRYS’s FA Score shows that 0 FA rating(s) are green whileROIV’s FA Score has 0 green FA rating(s).

  • KRYS’s FA Score: 0 green, 5 red.
  • ROIV’s FA Score: 0 green, 5 red.
According to our system of comparison, KRYS is a better buy in the long-term than ROIV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KRYS’s TA Score shows that 4 TA indicator(s) are bullish while ROIV’s TA Score has 4 bullish TA indicator(s).

  • KRYS’s TA Score: 4 bullish, 4 bearish.
  • ROIV’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, ROIV is a better buy in the short-term than KRYS.

Price Growth

KRYS (@Biotechnology) experienced а +5.81% price change this week, while ROIV (@Biotechnology) price change was +2.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.16%. For the same industry, the average monthly price growth was +20.27%, and the average quarterly price growth was +6.37%.

Reported Earning Dates

KRYS is expected to report earnings on Aug 11, 2025.

ROIV is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+8.16% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ROIV($7.67B) has a higher market cap than KRYS($3.96B). KRYS has higher P/E ratio than ROIV: KRYS (32.87) vs ROIV (1.97). ROIV YTD gains are higher at: -3.043 vs. KRYS (-10.424). ROIV has higher annual earnings (EBITDA): 4.1B vs. KRYS (140M). ROIV has more cash in the bank: 5.15B vs. KRYS (617M). KRYS has less debt than ROIV: KRYS (9.66M) vs ROIV (100M). KRYS has higher revenues than ROIV: KRYS (333M) vs ROIV (123M).
KRYSROIVKRYS / ROIV
Capitalization3.96B7.67B52%
EBITDA140M4.1B3%
Gain YTD-10.424-3.043343%
P/E Ratio32.871.971,672%
Revenue333M123M271%
Total Cash617M5.15B12%
Total Debt9.66M100M10%
FUNDAMENTALS RATINGS
KRYS: Fundamental Ratings
KRYS
OUTLOOK RATING
1..100
15
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
PROFIT vs RISK RATING
1..100
44
SMR RATING
1..100
57
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
KRYSROIV
RSI
ODDS (%)
Bullish Trend 2 days ago
82%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
69%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
64%
MACD
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
63%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
63%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
63%
Advances
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 11 days ago
71%
Declines
ODDS (%)
Bearish Trend 23 days ago
76%
Bearish Trend 9 days ago
73%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
76%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
67%
View a ticker or compare two or three
Interact to see
Advertisement
KRYS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
PSCC34.190.14
+0.41%
Invesco S&P SmallCap Consumer Stapl ETF
JMOM62.170.24
+0.39%
JPMorgan US Momentum Factor ETF
FPXI54.860.14
+0.26%
First Trust International Eq Opps ETF
ELC20.110.03
+0.15%
Entergy Louisiana LLC
LEO5.82N/A
+0.05%
BNY Mellon Strategic Municipals

ROIV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROIV has been loosely correlated with IMVT. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if ROIV jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROIV
1D Price
Change %
ROIV100%
+1.68%
IMVT - ROIV
61%
Loosely correlated
-1.30%
CRNX - ROIV
52%
Loosely correlated
-0.49%
ACLX - ROIV
52%
Loosely correlated
+0.51%
CGON - ROIV
50%
Loosely correlated
+1.22%
KRYS - ROIV
50%
Loosely correlated
+0.51%
More